Any analytical technology can offer results, but BioScale’s unique, flexible assay format, rapid assay development capability, and broad application portfolio offers you much more.   In a word - Insight.   AMMP assays elucidate results allowing better decisions to be made and giving you dependable choices quickly.

The flexibility of AMMP® assays and the ViBE® platform makes them ideal solutions for research applications across the drug development spectrum including early discovery and development, preclinical development, clinical trials, protein expression and bioprocess testing.  Our application expertise includes Drug Development in key therapeutic areas, Protein Research into cell signaling pathways and cytokines, and Clinical Research applications in most biological matrices.

The ViBE platform is an integral part of drug development research including biomarker monitoring and mesuring protein biomarkers for key therapeutic areas, including, oncology, inflammation, cardiovascular and CNS diseases.

Protein research is a vast discipline requiring the flexibility to search for and measure proteins in a wide array of sample types.  The ViBE used with AMMP assays can address changing needs for analysis of cell signaling pathways, cytokines and other biomarkers.

AMMP assays measure endogenous levels of low abundance biomarkers  with unrivaled sensitiviety and reporducibility in clinical matrices such as, lysates, tumors, serum, plasma, urine and amniotic fluid.